Dr. Agarwal’s Health Care Ltd. raises over 1,000 Crore funding from TPG Growth and Temasek

Chennai-based Dr. Agarwal’s Health Care Ltd. (DAHCL) has closed a landmark fund raise of 1,050 crore from TPG Growth, the middle market and growth equity platform of alternative asset firm Texas Pacific Group which is one of the leading investment firms based out of the US, and from existing investor Temasek, a global investment company headquartered in Singapore. 

The investment round, which is India’s largest fund raise in the eyecare space, will also provide significant capital to fuel the company’s expansion plans and pave the way for an exit for existing investor, ADV Partners. The company also raised RS 270 crores investment from Temasek in 2019. 
Professor (Dr.) Amar Agarwal, Chairman, Dr. Agarwal’s Group of Eye Hospitals: “We have had a great journey with our investor, ADV Partners, over the past 6 years. 

We are very excited to partner with TPG Growth and Temasek and look forward to the next phase of growth of our company. The new investments will be used to expand our Indian and international footprint and deploy latest technologies for super-specialty eyecare.”

Ankur Thadani, MD of TPG Growth: “We are delighted to be working with Dr. Agarwal’s Group of Eye Hospitals. We are proud to be partnering with the number one private eye care chain in the country to continue delivering critical eye care to a market that has a disproportionately high incidence of visual impairment.” Suresh Prabhala, Co-Founder and Managing Partner,  ADV Partners: 

“We feel the Dr. Agarwal’s Group of Eye Hospitals  is well poised to take advantage of the tremendous 
growth potential in the future and we wish the management and the Group continued success.”